Weight Loss
Semaglutide and Fatty Liver: What the Latest MASH Study Found
Learn how semaglutide and fatty liver may affect MASH and liver fibrosis
August 28, 2026
PR NEWS
Category : Weight Loss
Read More »
Weight Loss
Fatty Liver and Metabolic Health: Why Weight and Insulin Resistance Matter
Learn how Fatty Liver and Metabolic Health is linked to obesity and insulin resistance, what MASH means.
August 28, 2026
Weight Loss
Protecting Your Heart Health
Many people think about weight management mainly in terms of appearance, clothing size, or body shape. However, weight is also closely connected with the health of the heart and blood vessels. Excess body weight can affect blood pressure, cholesterol levels, blood sugar control, inflammation, and the amount of fat stored
August 26, 2026
Weight Loss
Semaglutide and Heart Health
Learn how semaglutide may affect heart health, cardiovascular risk, and weight management based on the SELECT trial in adults with obesity.
August 26, 2026
Weight Loss
Weight Loss Drugs: 4 Crucial Reasons the Strongest Option May Be Wrong for You
There is a question we get asked almost every week with regards to weight loss: which one works better Mounxxxx or Wegxxx? It is an understandable question, and there is an answer. In the first head to head trial comparing tirzepatide and semaglutide, tirzepatide (Mounxxxx) produced greater average weight loss
August 26, 2026
Weight Loss
Why BMI 25 Can Matter in Thailand: What Asian Obesity Research Shows
If you have ever checked your BMI using an international calculator, you may have seen a BMI of 25 described as “overweight” rather than obesity. But in Thailand and several other Asian countries, the picture is different. Asian populations can develop higher levels of body fat and visceral fat at
August 25, 2026